HowardIRutmanMDMBA, FACC
Cardiology • Bronx, NYAdult Congenital Heart Disease
Assistant Clinical Professor, Medicine, Cardiology, Albert Einstein College of Medicine
Dr. Rutman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
EKG Associates
111 East 210TH Street
Bronx, NY 10467Phone+1 718-405-8477Fax+1 718-405-8476
Education & Training
Einstein/Montefiore Med Ctr1986
Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 1984 - 1985
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1981 - 1984
Johns Hopkins University School of MedicineClass of 1981
Certifications & Licensure
NY State Medical License 1982 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 3 citationsIvermectin versus malathion for head lice.Howard Rutman
The New England Journal of Medicine. 2010-06-24 - 13 citationsRegional blood flow and neurohormonal responses to milrinone in congestive heart failureRobert J. Cody, Spencer H. Kubo, Andrew B. Covit, Franco B. Muller, Howard Rutman
Clinical Pharmacology and Therapeutics. 1986-02-01 - 72 citationsMilrinone in congestive heart failure: Acute and chronic hemodynamic and clinical evaluationCharles A. Simonton, Kanu Chatterjee, Robert J. Cody, Spencer H. Kubo, Daniel Leonard
Journal of the American College of Cardiology. 1985-08-01
Authored Content
- Clinical Events After Interruption of Anticoagulation in Patients with Atrial Fibrillation: An Analysis from the ENGAGE AF-TIMI 48 Trial☆February 2018
- Clinical Events After Interruption of Anticoagulation in Patients with Atrial Fibrillation: An Analysis from the ENGAGE AF-TIMI 48 Trial☆February 2018
Press Mentions
Chutes & Ladders—Gossamer Vet Salter-Cid Dons CSO Mantle at Flagship's New Pioneering Medicines UnitMay 14th, 2021- As Codiak Enters 'Next Phase of Growth,' Jennifer Wheler Steps into CMO Role; Mark Timney Lines up His Second CEO Opportunity After Purdue Pharma ReignMay 14th, 2021
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
